Case Report
===========

In patients with chronic kidney disease, sevelamer is used to treat hyperphosphatemia; the mechanism of action is intestinal binding of phosphate and subsequent fecal clearance. Known gastrointestinal (GI) side effects include nausea, vomiting, diarrhea, dyspepsia, and, more rarely, abdominal pain and constipation.[@B1] A 42-year-old woman with hyperphosphatemia secondary to end-stage renal disease was being treated with 800 mg sevelamer every 8 hours. She presented with left lower quadrant abdominal pain and watery diarrhea. Stool cultures and polymerase chain reaction were negative for *Clostridium difficile* infection. Esophagogastroduodenoscopy revealed grade D esophagitis (histochemical staining was negative for cytomegalovirus, herpes simplex virus, and sevelamer crystals) and a 3-cm hiatal hernia but was otherwise normal. Colonoscopy showed a 6 cm, fungating, oozing mass in the proximal sigmoid colon with no evidence of obstruction ([Figure 1](#F1){ref-type="fig"}). Biopsy of the mass showed necrotic tissue with bacterial overgrowth. Acid-fast and periodic acid-Schiff stain highlighted eosinophilic fish-scale crystals consistent with sevelamer deposition ([Figure 2](#F2){ref-type="fig"}).[@B2] After sevelamer was discontinued, repeat colonoscopy at 3 months showed normal pink mucosa with healthy blood vessels throughout the entire colon ([Figure 3](#F3){ref-type="fig"}).

![Colonoscopic image of fungating mass in the proximal sigmoid colon.](CG-CGCR170056F001){#F1}

![(A) Biopsy of specimen showing inflammatory, necrotic debris, and sevelamer crystals (arrow). (B) Magnified view of sevelamer crystals.](CG-CGCR170056F002){#F2}

![Follow-up colonoscopy at 3 months showing healthy mucosa throughout the colon.](CG-CGCR170056F003){#F3}

Sevelamer is a non-absorbable, phosphate-binding resin that acts in the GI tract to limit the absorption of phosphate. It has shown great clinical efficacy in patients with hyperphosphatemia secondary to chronic kidney disease.[@B1] While GI side effects have been well described, only rare cases have reported serious GI sequelae. One case described a case of colonic fecolith obstruction secondary to sevelamer use given the accumulation of crystals in the biopsy specimen.[@B3] Patients have been described with ulceration of the sigmoid colon.[@B4] On histology, sevelamer crystals were also discovered; however, these crystals were not associated with the formation of an obstruction or mass. A similar case reported a patient with nonbloody diarrhea found to have a colonic mass secondary to sevelamer ingestion.[@B5] Unfortunately, follow-up colonoscopy was not reported in this case. To our knowledge, ours is the first case to show complete remission of colonic mass after sevelamer discontinuation.
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